Vaccine Code Set Release Notes - 3/21/2024

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]



NCIRD National Center for Immunization and Respiratory Diseases

 

If this is a forwarded email, subscribe now to receive future updates on this topic.

 

Vaccine Code Set Update Publication Date: March 20, 2024
The individual filenames included in this distribution contain the publication date (20240320)

Release Notes:This release includes updates to all vaccine codes and maps but does not include Vaccine Information Statements (VIS) related code updates.

General Note Regarding this Release: Codes with “Last Update” dates after January 30, 2023, and before March 16, 2024, reflect the changes and additions in this release. This release includes the following code set updates:

  1. New Unspecified Anthrax Vaccine CVX Code 319 Added
  2. CPT To CVX Maps for Yellow Fever and DTaP Vaccines Updated
  3. New NDCs Added and Associated to Existing CVX, MVX, and Product
    1. New Southern Hemisphere Influenza Vaccines for 2024 Season
    2. Other New NDCs
  4. NDC Pairs Retired
  5. Other Updates to Existing NDC Records
  6. Other NDC Updates not Included in the Published Code Fields

Vaccine Code Set Updates – Details

  1. New Unspecified Anthrax Vaccine CVX Code 319 Added

A new unspecified CVX code has been added to allow recording of a historic vaccine administration where the formulation administered is not known. This has become necessary with the introduction of a second anthrax vaccine, CYFENDUS, which has a separate CVX code and formulation from the original Biothrax formulation (CVX code 24).

  • All anthrax CVX codes are associated with vaccine group ANTHRAX. The following CVX code has been added. Note that unspecified codes are added with a status of “Inactive”.
CVX CodeCVX Long DescriptionCVX Short DescriptionCVX Status
319
(NEW)
Anthrax vaccine, unspecified Anthrax vaccine, unspecified Inactive
  1. CPT to CVX Maps for Yellow Fever and DTaP Vaccines Updated
Change DescriptionCPT CodeCPT Long DescriptionCVX CodeCVX Long DescriptionCVX Note
Yellow Fever CPT to CVX Map Updates
Removed CPT to CVX map: CPT codes should not be mapped to unspecified codes. 90717 Yellow fever vaccine, live, for subcutaneous use 184 Yellow fever vaccine, unspecified formulation none
Added CPT to CVX map and updated CVX code description fields: Add reference to "live". CVX code 37 is associated to the YF-VAX product NDCs. 90717 Yellow fever vaccine, live, for subcutaneous use 37 yellow fever vaccine live This is the YF vaccine that has been available in the US for years. It is stabilized with sorbitol and gelatin.
Added CPT to CVX map and updated CVX code description and note fields: Add reference to use of this vaccine for a vaccine shortage. CVX code 183 is associated to the Stamaril product NDCs. 90717 Yellow fever vaccine, live, for subcutaneous use 183 Yellow fever vaccine live - alternative formulation for vaccine shortage This CVX is associated to an FDA unapproved drug to be used when there is a drug shortage. Stabilized with sorbitol and lactose and has been used outside the US for some time.
DTaP CPT to CVX Map Updates
Existing CPT to CVX map not changed: CVX code 20 is associated to Infantrix NDCs. 90700 Diphtheria, tetanus toxoids, and acellular pertussis vaccine (DTaP), when administered to individuals younger than 7 years, for intramuscular use 20 diphtheria, tetanus toxoids and acellular pertussis vaccine none
Added CPT to CVX map:CVX code 106 is associated to DAPTACEL NDCs. 90700 Diphtheria, tetanus toxoids, and acellular pertussis vaccine (DTaP), when administered to individuals younger than 7 years, for intramuscular use 106 diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens none
  1. New NDCs Added and Associated to Existing CVX, MVX, and Product
    1. New Southern Hemisphere Influenza Vaccines for 2024 Season
      The following three new vaccines have been added. Seasonal influenza vaccine tables have been updated on CDC’s website: Fall Season Respiratory Vaccine Codes | CDC
CVX CodeCVX Short DescriptionSale Proprietary NameSale LabelerMVX
Code
Sale NDC11Use NDC11Presentation
201 influenza, Southern Hemisphere, preservative free FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE Sanofi Pasteur Inc. PMC 49281-0324-50 49281-0324-88 SYRINGE, 0.5 mL
202 influenza, Southern Hemisphere, quadrivalent, with preservative FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE Sanofi Pasteur Inc. PMC 49281-0398-15 49281-0398-78 VIAL, MULTI-DOSE, 5 mL
231 influenza, Southern Hemisphere, high-dose, quadrivalent FLUZONE High-Dose Quadrivalent Southern Hemisphere Sanofi Pasteur Inc. PMC 49281-0933-50 49281-0933-88 SYRINGE, .7 mL
    1. Other New NDCs Added and Associated to Existing CVX, MVX, and Product
New relabeled NDCs for Merck’s PNEUMOVAX 23 product have been added by relabeler A-S Medication Solutions. The MVX code is assigned to the manufacturer.
Sale Proprietary NameSale LabelerSale NDC11Use NDC11CVX CodeCVX DescriptionMVX Code
PNEUMOVAX 23 A-S Medication Solutions 50090-7036-00 50090-7036-01 33 pneumococcal polysaccharide PPV23 MSD
  1. NDC Pairs Retired
The following NDC pairs have been updated with Unit of Sale and Unit of Use end dates to reflect retirement.
Sale Proprietary NameSale LabelerSale NDC11Use NDC11CVX CodeCVX DescriptionMVX Code
RabAvert GlaxoSmithKline Biologicals SA 58160-0964-12 58160-0966-01 176 Rabies - IM fibroblast culture SKB
RabAvert A-S Medication Solutions 50090-3096-00 58160-0966-01 176 Rabies - IM fibroblast culture SKB
FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE Sanofi Pasteur Inc. 49281-0355-15 49281-0355-78 202 influenza, Southern Hemisphere, quadrivalent, with preservative PMC
IPOL A-S Medication Solutions 50090-1693-09 50090-1693-00 10 IPV PMC
  1. Other Updates to Existing NDC Records

The following NDC updates are reflected in the vaccine code set files.

Change Description Sale Proprietary NameSale LabelerSale NDC11Use NDC11
Unit of Sale Route – corrected spelling of syringe HAVRIX A-S Medication Solutions 50090-1502-00 50090-1502-09
Unit of Use updated UseUnitPackform field for consistency MENQUADFI A-S Medication Solutions 50090-6180-00 50090-6180-01
  1. Other NDC Updates not Included in the Published Code Fields

In addition to the code updates and retired NDCs cited above, several Unit of Use and Unit of Sale NDCs in the vaccine code set show dates of last update in January 2024. These are due to minor changes on the FDA files or internal fields updated by CDC that are not reflected in the files CDC publishes but do update the date of last update in CDC’s code set database.

These NDCs include:

Sale Proprietary NameSale LabelerSale NDC11Use NDC11
IPOL A-S Medication Solutions 50090-1693-09 50090-1693-00
Comirnaty Pfizer Laboratories Div Pfizer Inc 00069-2025-10 00069-2025-01
PREHEVBRIO VBI Vaccines (Delaware) Inc. 75052-0001-10 75052-0001-01
PREVNAR 20 A-S Medication Solutions 50090-6026-00 50090-6026-01
Prevnar 20 Wyeth Pharmaceutical Division of Wyeth Holdings LLC 00005-2000-10 00005-2000-01
Prevnar 20 Wyeth Pharmaceutical Division of Wyeth Holdings LLC 00005-2000-02 00005-2000-01
TDVAX Grifols USA, LLC 13533-0131-01 13533-0131-00
TDVAX MassBiologics 14362-0111-04 14362-0111-03
TWINRIX GlaxoSmithKline Biologicals SA 58160-0815-52 58160-0815-43
TWINRIX GlaxoSmithKline Biologicals SA 58160-0815-48 58160-0815-43
Comirnaty Pfizer Laboratories Div Pfizer Inc 00069-2025-25 00069-2025-01
PREVNAR 13 Wyeth Pharmaceutical Division of Wyeth Holdings LLC 00005-1971-02 00005-1971-01
PREVNAR 13 Wyeth Pharmaceutical Division of Wyeth Holdings LLC 00005-1971-05 00005-1971-01
PREVNAR 13 Wyeth Pharmaceutical Division of Wyeth Holdings LLC, a subsidiary of Pfizer Inc. 00005-1971-04 00005-1971-01

Centers for Disease Control and Prevention

1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348
Questions or Problems  | 


[Index of Archives]     [NIH News]     [FDA News]     [USDA News]     [Yosemite News]     [Steve's Art]     [SB Lupus]     [STB]
  Powered by Linux